Medexus Pharmaceuticals Inc's market cap is currently ―. The company's EPS TTM is C$0.401; its P/E ratio is 3.89; Medexus Pharmaceuticals Inc is scheduled to report earnings on June 19, 2024, and the estimated EPS forecast is C$-0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 25.21M	$ 30.33M	$ 31.55M	$ 28.63M	$ 28.73M
Gross Profit	$ 12.69M	$ 16.28M	$ 17.24M	$ 15.02M	$ 15.93M
EBIT	$ 1.86M	$ 3.26M	$ 5.14M	$ 3.62M	$ 2.59M
EBITDA	$ 3.31M	$ 4.72M	$ 6.58M	$ 5.11M	$ 4.11M
Net Income Common Stockholders	$ -534.00K	$ -1.09M	$ 651.00K	$ 6.86M	$ -1.51M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.21M	$ 19.50M	$ 15.78M	$ 13.07M	$ 9.27M
Total Assets	$ 160.38M	$ 166.18M	$ 166.87M	$ 161.33M	$ 146.32M
Total Debt	$ 52.29M	$ 72.09M	$ 72.92M	$ 36.19M	$ 34.17M
Net Debt	$ 44.08M	$ 52.59M	$ 57.14M	$ 23.12M	$ 24.90M
Total Liabilities	$ 130.81M	$ 144.44M	$ 144.15M	$ 138.88M	$ 130.89M
Stockholders Equity	$ 29.56M	$ 21.74M	$ 22.73M	$ 22.45M	$ 15.43M
Cash Flow	-
Free Cash Flow	-	-	$ 4.19M	$ 3.69M	$ -2.22M
Operating Cash Flow	$ 5.54M	$ 7.35M	$ 4.21M	$ 3.86M	$ -2.20M
Investing Cash Flow	$ -1.75M	$ -592.00K	$ -597.00K	$ -695.00K	$ -538.00K
Financing Cash Flow	$ -22.76M	$ -2.96M	$ -968.00K	$ 598.00K	$ 2.42M

Currency in USD

Medexus Pharmaceuticals Inc Earnings and Revenue History

Income Statement >

Medexus Pharmaceuticals Inc Debt to Assets

Balance Sheet >

Medexus Pharmaceuticals Inc Cash Flow

Cash Flow >

Medexus Pharmaceuticals Inc Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing